Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,443 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Netflix walks away from an $83 billion Warner Bros. deal, freeing capital for expansion and content, lifting the stoc...
Capitol Hill politics put crypto regulation on a slower track, as a Senate leader signals the Clarity Act may not rea...
Ford’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
California Gov. Gavin Newsom warned 15 cities and counties they have 30 days to align their zoning with SB 79 or face...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
As retirement draws near, many wonder how to handle more retirement spending without draining resources. This guide o...
A one-way buying binge by STRC is outpacing U.S. spot BTC ETFs in peak weeks, raising questions about how STRC volati...
Bitcoin has moved back into a critical zone around $66,900 to $68,000, renewing questions about whether the price wil...
A loomingFed policy shift could push up borrowing costs for households. Analysts warn americans taxpayers could face ...